PRACTICE Guidelines REGISTRATION PLATFORM
News MORE
  • 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2024.0529
    Technological innovation has expanded the clinical application. Variable pulse technology enhances the thermal effect of the 2940nm laser, while long-pulsed technology allows the 1064nm laser to heat subcutaneous tissues and fat more safely to achieve skin rejuvenation, tightening, and fat reduction. To promote the more professional and standardized clinical application of the variable pulse 2940nm laser and long-pulsed 1064nm laser, a consensus writing group composed of experts from plastic surgery, dermatology, laser cosmetology, and burn departments was formed. Based on the current evidence-based medical evidence, clinical practice, and authoritative guidelines from other disciplines, this consensus was developed. It discusses the indications, treatment parameters, contraindications, and precautions of the variable pulse 2940nm laser and long-pulsed 1064nm laser and gives expert recommendations for clinical reference.
  • 2024.0529
    Since the 2022 Guideline for the management of patients with Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association published, great improvements have been made during the past two years. But the 2022 AHA /ASA Guideline lack of critical care management such as sedation and analgesia treatment、 airway management and nutrition support therapy for intracerebral hemorrhage patients,especially for critical care medical staff.Expert consensus is necessary to improve the critical care management of acute intracerebral hemorrhage . The writing committee met and discussed the narrative text and recommendations. The aim of this expert consensus is to present current and comprehensive recommendations for the critical care management of acute spontaneous intracerebral hemorrhage.
  • 2024.0528
    To summarize and analyze the available medical evidence to evaluate the efficacy and safety of off-label use of tumor necrosis factor antagonists in children with rheumatic immune diseases. Develop a set of expert consensus to provide guidance and reference for clinicians to optimize treatment regimens, improve treatment outcomes, and ensure the safety of children. Promote multidisciplinary cooperation, including rheumatology and immunology, pediatrics, clinical pharmacy, etc., to jointly improve the diagnosis and treatment of such diseases.
  • 2024.0527
    With the opening of China's fertility policy, the incidence of hypertension disorder in pregnancy (HDP), one of the most common diseases during pregnancy, is expected to increase significantly. HDP patients face increased risks of adverse pregnancy outcomes, metabolic abnormalities, and cardiovascular events during the perinatal and postpartum periods. This poses a significant threat to the life and health of pregnant women in China and imposes a heavy economic burden. Recent research suggests that a history of HDP can explain the majority (84%) of the increased cardiovascular risk in women post-pregnancy. Therefore, early intervention in the cardiovascular risk factors of HDP patients is crucial. To this end, it is necessary to establish a "Pregnancy-Heart Team" that involves collaboration between obstetrics and cardiology departments to reduce adverse events in HDP patients during the perinatal and postpartum periods. Currently, there is a lack of consensus on the comprehensive management of cardiovascular and metabolic risks for this population. The implementation of this consensus will help guide the assessment and management of cardiovascular disease risks and related risk factors in HDP patients in China, and promote the prevention and treatment of cardiovascular risks associated with HDP in primary care.
  • 2024.0526
    Cardiovascular and cerebrovascular diseases are common and frequently-occurring diseases in middle-aged and elderly people, which seriously threaten the health of the population. Cardiovascular diseases and cerebrovascular diseases have similar pathogenesis to a certain extent, so the situation of cardio-cerebral comorbidity is also more common, and the probability of cerebral complications after cardiac surgery is also higher than that of other non-neurological and non-vascular surgeries. The diagnosis and treatment of cardiac surgery patients with cerebrovascular diseases is more difficult, and the brain complications after cardiac surgery will seriously threaten the survival and quality of life of patients. Therefore, it is urgent to establish a standard prevention and treatment system for cerebral complications in cardiac surgery. At present, there is no authoritative guide and expert consensus in the field of brain and heart treatment in China. Therefore, from the perspective of cardiac surgery, the Chinese Society of Thoracic and Cardiovascular Surgery organized domestic experts in cardiac surgery, neurosurgery, anesthesiology, critical care and other disciplines to summarize corresponding diagnosis and treatment strategies in different fields of cardiac surgery by referring to relevant domestic and foreign consensus, guidelines, and literature, combined with the clinical practice in China. In order to provide reference for the clinical practice of treating brain with heart and brain, the paper also introduces different brain protective devices and their applications in cardiac surgery.
Registration process and operational mode of a CPG registry